Joshua L Dunaief Selected Research

Monomeric GTP-Binding Proteins

12/2019

Dexras1 Deletion and Iron Chelation Promote Neuroprotection in Experimental Optic Neuritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua L Dunaief Research Topics

Disease

48	Macular Degeneration (Age-Related Maculopathy) 12/2023 - 05/2003
29	Retinal Degeneration 04/2024 - 04/2003
28	Iron Overload 01/2023 - 09/2004
12	Inflammation (Inflammations) 11/2022 - 08/2004
11	Retinal Diseases 01/2022 - 09/2004
10	Geographic Atrophy 01/2022 - 05/2003
9	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 08/2004
6	Hypertrophy 01/2019 - 09/2004
5	Blindness (Hysterical Blindness) 01/2022 - 03/2011
4	Glaucoma 02/2023 - 11/2007
4	Hemochromatosis (Bronze Diabetes) 01/2023 - 11/2006
4	Choroidal Neovascularization 11/2021 - 09/2008
4	Hemorrhage 10/2019 - 10/2007
4	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 05/2003
3	Anemia 10/2019 - 09/2009
3	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2019 - 09/2009
3	Atrophy 01/2019 - 06/2005
3	Inborn Genetic Diseases (Disease, Hereditary) 10/2018 - 11/2006
3	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 10/2018 - 10/2007
3	Friedreich Ataxia (Friedreich's Ataxia) 10/2018 - 11/2007
2	Chronic Disease (Chronic Diseases) 11/2022 - 11/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 01/2017
2	Ocular Hypertension (Glaucoma, Suspect) 11/2020 - 01/2020
2	Siderosis 01/2020 - 10/2007
2	Multiple Sclerosis 01/2020 - 12/2019
2	Optic Nerve Diseases (Optic Neuropathy) 12/2019 - 07/2009
2	Thrombosis (Thrombus) 01/2019 - 01/2019
2	Disease Progression 01/2019 - 10/2004
2	Tauopathies 01/2019 - 10/2017
2	Eye Diseases (Eye Disease) 01/2016 - 07/2009
2	Iron Deficiencies 01/2014 - 11/2007
2	Hyperplasia 06/2008 - 09/2004
1	Type 2 Diabetes Mellitus (MODY) 02/2023
1	Neuroinflammatory Diseases 02/2023
1	Phototoxic Dermatitis (Phototoxicity) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2021
1	Dementia (Dementias) 11/2021
1	Migraine Disorders (Migraine) 11/2021
1	Sympathetic Ophthalmia (Sympathetic Uveitis) 11/2021
1	Retinal Dystrophies 06/2020
1	Optic Neuritis (Retrobulbar Neuritis) 12/2019
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2019

Drug/Important Bio-Agent (IBA)

56	IronIBA 01/2023 - 08/2003
43	Retinaldehyde (Retinal)IBA 02/2023 - 04/2003
13	Ceruloplasmin (Ferroxidase)IBA 01/2023 - 04/2003
12	Familial apoceruloplasmin deficiencyIBA 10/2018 - 09/2004
11	Chelating AgentsIBA 11/2021 - 07/2009
9	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2004
8	Complement System Proteins (Complement)IBA 01/2020 - 01/2012
7	AntioxidantsIBA 11/2021 - 08/2004
7	DeferiproneIBA 01/2020 - 02/2011
6	Isoflurophate (DFP)FDA Link 01/2020 - 02/2011
4	sodium iodateIBA 04/2024 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2014
4	LipofuscinIBA 01/2019 - 11/2006
3	Retinal Pigments (Pigments, Visual)IBA 12/2023 - 01/2016
3	EnzymesIBA 01/2023 - 01/2016
3	Ferritins (Ferritin)IBA 06/2022 - 12/2005
3	A-factor (Streptomyces)IBA 01/2019 - 11/2006
2	Glucagon-Like Peptide-1 ReceptorIBA 02/2023 - 11/2020
2	HepcidinsIBA 01/2023 - 06/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 07/2009
2	C-Reactive ProteinIBA 11/2022 - 11/2021
2	metal transporting protein 1 (ferroportin)IBA 01/2022 - 12/2005
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2021
2	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2017
2	Complement Factor H (Factor H)IBA 01/2019 - 01/2019
2	CopperIBA 01/2018 - 07/2006
2	InflammasomesIBA 06/2015 - 05/2012
2	Transcription Factors (Transcription Factor)IBA 11/2014 - 08/2004
2	RNA (Ribonucleic Acid)IBA 05/2012 - 03/2011
2	Heme Oxygenase-1IBA 01/2012 - 01/2012
1	Selective Estrogen Receptor Modulators (SERM)IBA 04/2024
1	Tamoxifen FDA LinkGeneric 04/2024
1	Blood Glucose (Blood Sugar)IBA 02/2023
1	Lipid PeroxidesIBA 01/2023
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2022
1	PhytochemicalsIBA 06/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	SynucleinsIBA 01/2022
1	DeuteriumIBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	Docosahexaenoic AcidsIBA 01/2022
1	ferric ammonium citrate FDA Link 11/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	Ranibizumab (Lucentis)FDA Link 07/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020
1	CytokinesIBA 11/2020
1	compstatinIBA 01/2020
1	Monomeric GTP-Binding ProteinsIBA 12/2019
1	MetalsIBA 12/2019
1	Glutamic Acid (Glutamate)FDA Link 12/2019

Therapy/Procedure

9	Therapeutics 12/2023 - 11/2006
1	Plant-Based Diet 06/2022
1	Oral Administration 01/2020
1	Microspheres (Microsphere) 01/2020
1	Injections 01/2020